Search Results

Your search for Janssen Pharmaceuticals, Inc. in News Releases returned 2 results

News Releases

• May 07, 2013, 07:00 ET

  The Scripps Research Institute Announces New Research and License Agreement with Janssen Pharmaceuticals, Inc.

   The Scripps Research Institute (TSRI) today announced a five-year agreement with Janssen Pharmaceuticals, Inc. (Janssen) to collaborate on focused research projects in the infectious disease area, with the initial project targeting the influenza virus. Under the agreement Janssen will receive...

  More news about: The Scripps Research Institute , Janssen Pharmaceuticals, INc.

• Mar 29, 2013, 16:37 ET

  U.S. FDA Approves INVOKANA™ (Canagliflozin) for the Treatment of Adults with Type 2 Diabetes

  Janssen Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration (FDA) has approved INVOKANA™ (canagliflozin) for the treatment of adults with type 2 diabetes. INVOKANA™ is the first in a new class of medications called sodium glucose co-transporter 2...

  More news about: Janssen Pharmaceuticals, Inc.